Ginkgo Bioworks (DNA) Stock: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$6.75
-0.03 (-0.44%)
▼
5d:
-2.88%
30d:
-6.38%
90d:
-15.62%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $6.75, which is considered slightly low relative to its 30-day fair value range of $6.64 to $7.84.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $6.52, while resistance sits at $7.30.
Market Sentiment: DNA scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $6.52, while resistance sits at $7.30.
Market Sentiment: DNA scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.64 -
$7.84
Company Quality Score
54/100
(HOLD)
Options IV Signal
35th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 35th percentile)
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($7.00)
Trading Range Analysis
30-Day Trading Range
$6.64 -
$7.84
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.77
(11.4%)
Support & Resistance Levels
Support Level
$6.52
Resistance Level
$7.30
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$7.00
(+3.7%)
Revenue Growth (YoY)
-48.5%
Profit Margin
-219.6%
Share & Embed Analysis
Last updated: September 13, 2026 1:49 AM ET
Data refreshes hourly during market hours. Next update: 2:49 AM
Data refreshes hourly during market hours. Next update: 2:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
